← All stories
Markets

Oxford Nanopore (LSE:ONT): How Far Does the Rare Disease Partnership Reach?

1 source ·1 article ·2h ago

Highlights An agreement will incorporate the group's sequencing technology into a rare disease diagnostic platform. A chief medical officer has joined, with a chief marketing and communications officer following. Management continues to tar…

Covered by 1 outlet

All coverage · 1 article